BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26728471)

  • 1. Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer: the B ∼ FIT Cohort.
    Dallal CM; Lacey JV; Pfeiffer RM; Bauer DC; Falk RT; Buist DS; Cauley JA; Hue TF; LaCroix AZ; Tice JA; Veenstra TD; Xu X; Brinton LA;
    Horm Cancer; 2016 Feb; 7(1):49-64. PubMed ID: 26728471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen metabolism and risk of breast cancer in postmenopausal women.
    Fuhrman BJ; Schairer C; Gail MH; Boyd-Morin J; Xu X; Sue LY; Buys SS; Isaacs C; Keefer LK; Veenstra TD; Berg CD; Hoover RN; Ziegler RG
    J Natl Cancer Inst; 2012 Feb; 104(4):326-39. PubMed ID: 22232133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B~FIT.
    Dallal CM; Tice JA; Buist DS; Bauer DC; Lacey JV; Cauley JA; Hue TF; Lacroix A; Falk RT; Pfeiffer RM; Fuhrman BJ; Veenstra TD; Xu X; Brinton LA;
    Carcinogenesis; 2014 Feb; 35(2):346-55. PubMed ID: 24213602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthropometric measures and serum estrogen metabolism in postmenopausal women: the Women's Health Initiative Observational Study.
    Oh H; Coburn SB; Matthews CE; Falk RT; LeBlanc ES; Wactawski-Wende J; Sampson J; Pfeiffer RM; Brinton LA; Wentzensen N; Anderson GL; Manson JE; Chen C; Zaslavsky O; Xu X; Trabert B
    Breast Cancer Res; 2017 Mar; 19(1):28. PubMed ID: 28284224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating estrogens and postmenopausal ovarian and endometrial cancer risk among current hormone users in the Women's Health Initiative Observational Study.
    Trabert B; Coburn SB; Falk RT; Manson JE; Brinton LA; Gass ML; Kuller LH; Rohan TE; Pfeiffer RM; Qi L; Stefanick ML; Wentzensen N; Anderson GL; Xu X
    Cancer Causes Control; 2019 Nov; 30(11):1201-1211. PubMed ID: 31542834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study.
    Falk RT; Brinton LA; Dorgan JF; Fuhrman BJ; Veenstra TD; Xu X; Gierach GL
    Breast Cancer Res; 2013 Apr; 15(2):R34. PubMed ID: 23607871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort.
    Dallal CM; Brinton LA; Bauer DC; Buist DS; Cauley JA; Hue TF; Lacroix A; Tice JA; Chia VM; Falk R; Pfeiffer R; Pollak M; Veenstra TD; Xu X; Lacey JV;
    Endocr Relat Cancer; 2013 Feb; 20(1):151-60. PubMed ID: 23222000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women.
    Brinton LA; Trabert B; Anderson GL; Falk RT; Felix AS; Fuhrman BJ; Gass ML; Kuller LH; Pfeiffer RM; Rohan TE; Strickler HD; Xu X; Wentzensen N
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1081-9. PubMed ID: 27197275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers.
    Brown SB; Hankinson SE
    Steroids; 2015 Jul; 99(Pt A):8-10. PubMed ID: 25555473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiologic studies of estrogen metabolism and breast cancer.
    Ziegler RG; Fuhrman BJ; Moore SC; Matthews CE
    Steroids; 2015 Jul; 99(Pt A):67-75. PubMed ID: 25725255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Endogenous Pregnenolone, Progesterone, and Related Metabolites with Risk of Endometrial and Ovarian Cancers in Postmenopausal Women: The B
    Trabert B; Geczik AM; Bauer DC; Buist DSM; Cauley JA; Falk RT; Gierach GL; Hue TF; Lacey JV; LaCroix AZ; Michels KA; Tice JA; Xu X; Brinton LA; Dallal CM
    Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2030-2037. PubMed ID: 34465588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Active and Sedentary Behaviors with Postmenopausal Estrogen Metabolism.
    Dallal CM; Brinton LA; Matthews CE; Pfeiffer RM; Hartman TJ; Lissowska J; Falk RT; Garcia-Closas M; Xu X; Veenstra TD; Gierach GL
    Med Sci Sports Exerc; 2016 Mar; 48(3):439-48. PubMed ID: 26460631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancer.
    Zeleniuch-Jacquotte A; Shore RE; Afanasyeva Y; Lukanova A; Sieri S; Koenig KL; Idahl A; Krogh V; Liu M; Ohlson N; Muti P; Arslan AA; Lenner P; Berrino F; Hallmans G; Toniolo P; Lundin E
    Br J Cancer; 2011 Oct; 105(9):1458-64. PubMed ID: 21952628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating estrogen metabolites and risk of breast cancer in postmenopausal women.
    Arslan AA; Koenig KL; Lenner P; Afanasyeva Y; Shore RE; Chen Y; Lundin E; Toniolo P; Hallmans G; Zeleniuch-Jacquotte A
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1290-7. PubMed ID: 24769889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary estrogen metabolites and breast cancer: a combined analysis of individual level data.
    Dallal CM; Stone RA; Cauley JA; Ness RB; Vogel VG; Fentiman IS; Fowke JH; Krogh V; Loft S; Meilahn EN; Muti P; Olsen A; Overvad K; Sieri S; Tjønneland A; Ursin G; Wellejus A; Taioli E
    Int J Biol Markers; 2013 Apr; 28(1):3-16. PubMed ID: 22865302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen Metabolites Are Not Associated with Colorectal Cancer Risk in Postmenopausal Women.
    Falk RT; Dallal CM; Lacey JV; Bauer DC; Buist DS; Cauley JA; Hue TF; LaCroix AZ; Tice JA; Pfeiffer RM; Xu X; Veenstra TD; Brinton LA;
    Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1419-22. PubMed ID: 26104910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Luhn P; Dallal CM; Weiss JM; Black A; Huang WY; Lacey JV; Hayes RB; Stanczyk FZ; Wentzensen N; Brinton LA
    Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1304-12. PubMed ID: 23696194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women.
    Eliassen AH; Spiegelman D; Xu X; Keefer LK; Veenstra TD; Barbieri RL; Willett WC; Hankinson SE; Ziegler RG
    Cancer Res; 2012 Feb; 72(3):696-706. PubMed ID: 22144471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Estrogens and Postmenopausal Ovarian Cancer Risk in the Women's Health Initiative Observational Study.
    Trabert B; Brinton LA; Anderson GL; Pfeiffer RM; Falk RT; Strickler HD; Sliesoraitis S; Kuller LH; Gass ML; Fuhrman BJ; Xu X; Wentzensen N
    Cancer Epidemiol Biomarkers Prev; 2016 Apr; 25(4):648-56. PubMed ID: 26908437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous Estrogens, Estrogen Metabolites, and Breast Cancer Risk in Postmenopausal Chinese Women.
    Moore SC; Matthews CE; Ou Shu X; Yu K; Gail MH; Xu X; Ji BT; Chow WH; Cai Q; Li H; Yang G; Ruggieri D; Boyd-Morin J; Rothman N; Hoover RN; Gao YT; Zheng W; Ziegler RG
    J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27193440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.